321 related articles for article (PubMed ID: 9542677)
1. Epidemiology and in vitro activity of antimycotics against candidal vaginal/skin/nail infections in Singapore.
Kwok YK; Tay YK; Goh CL; Kamarudin A; Koh MT; Seow CS
Int J Dermatol; 1998 Feb; 37(2):145-9. PubMed ID: 9542677
[TBL] [Abstract][Full Text] [Related]
2. Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis).
Mendling W; Brasch J; Cornely OA; Effendy I; Friese K; Ginter-Hanselmayer G; Hof H; Mayser P; Mylonas I; Ruhnke M; Schaller M; Weissenbacher ER
Mycoses; 2015 Mar; 58 Suppl 1():1-15. PubMed ID: 25711406
[TBL] [Abstract][Full Text] [Related]
3. Emergence of non-Candida albicans species: Epidemiology, phylogeny and fluconazole susceptibility profile.
Sadeghi G; Ebrahimi-Rad M; Mousavi SF; Shams-Ghahfarokhi M; Razzaghi-Abyaneh M
J Mycol Med; 2018 Mar; 28(1):51-58. PubMed ID: 29366545
[TBL] [Abstract][Full Text] [Related]
4. Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases.
Richter SS; Galask RP; Messer SA; Hollis RJ; Diekema DJ; Pfaller MA
J Clin Microbiol; 2005 May; 43(5):2155-62. PubMed ID: 15872235
[TBL] [Abstract][Full Text] [Related]
5. [Vaginal candidiasis: etiology and sensitivity profile to antifungal agents in clinical use].
Saporiti AM; Gómez D; Levalle S; Galeano M; Davel G; Vivot W; Rodero L
Rev Argent Microbiol; 2001; 33(4):217-22. PubMed ID: 11833253
[TBL] [Abstract][Full Text] [Related]
6. [Identification and in vitro antifungal susceptibility of vaginal Candida spp. isolates to fluconazole, clotrimazole and nystatin].
Diaz MC; Camponovo R; Araya I; Cerda A; Santander MP; Carrillo-Muñoz AJ
Rev Esp Quimioter; 2016 Jun; 29(3):151-4. PubMed ID: 27167765
[TBL] [Abstract][Full Text] [Related]
7. In vitro susceptibility profile of 200 recent clinical isolates of Candida spp. to topical antifungal treatments of vulvovaginal candidiasis, the imidazoles and nystatin agents.
Choukri F; Benderdouche M; Sednaoui P
J Mycol Med; 2014 Dec; 24(4):303-7. PubMed ID: 25442913
[TBL] [Abstract][Full Text] [Related]
8. Species distribution and antifungal susceptibility of Candida spp. isolated from superficial candidiasis in outpatients in Iran.
Razzaghi-Abyaneh M; Sadeghi G; Zeinali E; Alirezaee M; Shams-Ghahfarokhi M; Amani A; Mirahmadi R; Tolouei R
J Mycol Med; 2014 Jun; 24(2):e43-50. PubMed ID: 24767256
[TBL] [Abstract][Full Text] [Related]
9. In vitro antifungal sensitivity of fluconazole, clotrimazole and nystatin against vaginal candidiasis in females of childbearing age.
Khan F; Baqai R
J Ayub Med Coll Abbottabad; 2010; 22(4):197-200. PubMed ID: 22455297
[TBL] [Abstract][Full Text] [Related]
10. [Prerequisites for effective therapy of chronic recurrent vaginal candidiasis].
Kunzelmann V; Tietz HJ; Rossner D; Czaika V; Hopp M; Schmalreck A; Sterry W
Mycoses; 1996; 39 Suppl 1():65-72. PubMed ID: 8767274
[TBL] [Abstract][Full Text] [Related]
11. [Vulvovaginal candidiasis and sensitivity of pathogens to antimycotics].
Sojáková M; Liptajová D; Simoncicová M; Borovský M; Subík J
Ceska Gynekol; 2003 Jan; 68(1):24-9. PubMed ID: 12708111
[TBL] [Abstract][Full Text] [Related]
12. Antifungal susceptibilities of Candida species isolated from the patients with vaginal candidiasis.
Nagashima M; Yamagishi Y; Mikamo H
J Infect Chemother; 2016 Feb; 22(2):124-6. PubMed ID: 26627336
[TBL] [Abstract][Full Text] [Related]
13. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
[TBL] [Abstract][Full Text] [Related]
14. Reduced Antifungal Susceptibility of Vulvovaginal Candida Species at Normal Vaginal pH Levels: Clinical Implications.
Spitzer M; Wiederhold NP
J Low Genit Tract Dis; 2018 Apr; 22(2):152-158. PubMed ID: 29474241
[TBL] [Abstract][Full Text] [Related]
15. In vitro antifungal resistance profile of Candida strains isolated from Saudi women suffering from vulvovaginitis.
Yassin MT; Mostafa AA; Al-Askar AA; Bdeer R
Eur J Med Res; 2020 Jan; 25(1):1. PubMed ID: 31901238
[TBL] [Abstract][Full Text] [Related]
16. Species distribution and susceptibility of Candida isolates from patient with vulvovaginal candidiasis in Southern China from 2003 to 2012.
Liu XP; Fan SR; Peng YT; Zhang HP
J Mycol Med; 2014 Jun; 24(2):106-11. PubMed ID: 24746725
[TBL] [Abstract][Full Text] [Related]
17. [Fungi isolated from the vagina and their susceptibility to antifungals].
Macura AB; Skóra M
Ginekol Pol; 2012 Jun; 83(6):433-8. PubMed ID: 22880463
[TBL] [Abstract][Full Text] [Related]
18. [Isolation frequency and spectrum of sensitivity to antifungal preparations of vulvovaginal candidiasis pathogens].
Skliar TV; Krysenko AV; Sirokvasha EA; Vinnikov AI
Mikrobiol Z; 2007; 69(3):57-62. PubMed ID: 17682532
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of sertaconazole, fluconazole, ketoconazole, fenticonazole, clotrimazole and itraconazole against pathogenic vaginal yeast isolates.
Palacín C; Tarragó C; Agut J; Guglietta A
Methods Find Exp Clin Pharmacol; 2001 Mar; 23(2):61-4. PubMed ID: 11484411
[TBL] [Abstract][Full Text] [Related]
20. [In vitro activities of posaconazole, fluconazole, itraconazole, ketoconazole and voriconazole against Candida glabrata].
Blanco MT; Cañadas J; García-Martos P; Marín P; García-Tapia A; Rodríguez J
Rev Esp Quimioter; 2009 Sep; 22(3):139-43. PubMed ID: 19662547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
